This topic contains a solution. Click here to go to the answer

Author Question: Which ethnic group or gender is at greatest risk for developing metabolic syndrome? a. Hispanic ... (Read 59 times)

kellyjaisingh

  • Hero Member
  • *****
  • Posts: 540
Which ethnic group or gender is at greatest risk for developing metabolic syndrome?
 
  a. Hispanic women
  b. Asian men
  c. African American men
  d. White women

Question 2

Which instruction by the nurse is accurate to include in a patient's care to manage metabolic syndrome?
 
  a. Encourage the client to exercise 20 minutes every day.
  b. Eliminate alcohol intake.
  c. Increase simple carbohydrates in the diet.
  d. Reduce stress.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ciecieme

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

ANS: A
Hispanic women have the highest incidence rate of metabolic syndrome at 27. Asian men, African American men, and white women are not at the highest risk for metabolic syndrome.

Answer to Question 2

ANS: D
Stress reduction is important in the management of metabolic syndrome. Twenty minutes of exercise is not adequate. Alcohol intake needs to be restricted but does not have to be eliminated. Complex carbohydrates are appropriate in the management of metabolic syndrome.




kellyjaisingh

  • Member
  • Posts: 540
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


ryhom

  • Member
  • Posts: 366
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library